ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 88 filers reported holding ERASCA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233,071 | -24.7% | 118,310 | +5.5% | 0.00% | – |
| Q2 2023 | $309,644 | -47.2% | 112,190 | -42.4% | 0.00% | – |
| Q1 2023 | $586,017 | -93.2% | 194,690 | -90.2% | 0.00% | -100.0% |
| Q4 2022 | $8,598,299 | -73.4% | 1,994,965 | -51.8% | 0.00% | -75.0% |
| Q3 2022 | $32,316,000 | +42.7% | 4,143,124 | +1.9% | 0.02% | +60.0% |
| Q2 2022 | $22,647,000 | -22.4% | 4,065,829 | +19.8% | 0.01% | -9.1% |
| Q1 2022 | $29,186,000 | -42.5% | 3,393,731 | +4.2% | 0.01% | -38.9% |
| Q4 2021 | $50,739,000 | -5.4% | 3,256,646 | +28.9% | 0.02% | -14.3% |
| Q3 2021 | $53,624,000 | – | 2,527,031 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 2,500,000 | $19,500,000 | 13.59% |
| ARCH Venture Management, LLC | 11,055,554 | $86,233,000 | 11.18% |
| EDBI Pte Ltd | 888,888 | $6,933,000 | 7.30% |
| Cormorant Asset Management, LP | 10,505,554 | $81,943,000 | 5.73% |
| AH Equity Partners V, L.L.C. | 50,000 | $390,000 | 2.53% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $2,438,000 | 2.18% |
| PFM Health Sciences, LP | 7,264,981 | $56,667,000 | 2.05% |
| Artal Group S.A. | 3,172,221 | $24,743,000 | 1.06% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 472,472 | $3,685,000 | 0.75% |
| EcoR1 Capital, LLC | 678,441 | $5,292,000 | 0.16% |